(Part 3) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part Three: Election Day special: Regulatory Obstacles (continued from Part Two)

By Ellen Martin


Here is a 352-page description of US healthcare regulation as of 2006: Robert I. Field’s Health Care Regulation in America: Complexity, Confrontation, and Compromise.

It is always mind boggling to hear so many people toss throwaway lines about the failures or limits of the “free market” in Silicon Valley; anyone with a view into enterprise IT or any other aspect of running businesses for employers, providers, insurers, pharmaceuticals, or device companies must handle a broad and deep maze of regulations.

Various attempts have been made to calculate the annual costs of regulation in healthcare. For example, the Cato Institute back in 2004 estimated an annual cost of $169.1 billion (with a very big error bar) of net benefits.

Federal Healthcare

Most of the Federal agencies directly involved in healthcare fall under Health and Human Services. HHS has ten sub-agencies (see the HHS org chart for a complete 2012 list).

I’ll just call out the main four that are most relevant to this data discussion:

  • NIH: medical research, funding
  • FDA: marketing, safety, and manufacturing of pharmaceuticals, biologicals, medical devices and manufacturing
  • CDC: public health surveillance
  • CMS: Medicare and Medicaid plus institutional accreditation requirements. More importantly, setting reimbursement prices and codes that are used as benchmarks by private payers and providers.

The Department of Defense administers the Veterans Health Administration and the Military Health system. Medicare, Medicaid and the military health system, including veterans, pay for the care of about 30% of Americans in all.

Other Federal agencies that incidentally impact health care enterprises and IT requirements for reporting and compliance include OSHA, NLRB, ERISA, and the EPA.

Every state, county, and city is responsible for a myriad of licensing, accreditation, covering physicians, nurses, and other healthcare professionals. There are also a large number of non-government (self-regulating) organizations that are involved with licensure, accreditation, and oversight.


New Health Regulations

Since 2006, there have been big new regulatory initiates (HIPAA, ARRA, ACA aka Obamacare):

  • HIPAA: “Meaningful use”, medical records, privacy, with a huge impact on the IT of all healthcare-related organizations.
  • ARRA: (stimulus funds as incentives for EMR/EHR conversions, which require IT)
  • The ACA: even Kaiser Health News points how the new health exchanges (to pick one aspect of a 2000-page bill), present many new complications.

The health law, however, takes this simple idea and makes it extraordinarily complicated – if not impossible – to execute. By adding a litany of new minimum-insurance requirements and regulations to the original bipartisan idea, health insurance purchased through an exchange will likely end up more expensive than it is now.” 

A large number of complex regulations favor large organizations like insurers and providers who can devote entire departments to compliance and coping with multiple reporting requirements. These substantial organizations can also manage lobbying any political activity to push further regulation in their preferred directions. As I see from a small business perspective, this evidently disfavors smaller and innovative organizations and approaches. Consequently, obstacles like barriers to entry and costs of compliance restrain small organizations. Furthermore, hazards include “regulatory capture” (where the regulated control the direction and enforcement—e.g., certain IT vendors, “green light bulbs”), cronyism (where politically well-connected organizations earn legislative and enforcement favors), or outside contractors who benefit from the new streams of tax moneys available to build out further regulation. See this discussion for more.

Today’s Healthcare System in the United States

Finally, here’s a link to a post that sums up the complexity of the current US healthcare system, not just regulation, of course, but all the complexity generated by the employer-provided, third-party payer system.

Most common solutions revolve around more regulation. This concept assumes that markets are only subject to failure and the government will never fail in order to eliminate self-interest and streamline the system.

Tim O’Reilly suggested at StrataRx, “Maybe we’d love government as much as Apple if the interfaces were better.” Would the impacts of all of the above on enterprise IT planning and implementation be significantly mitigated by better interfaces?

The next post will outline some of the IT-specific obstacles.



On Key

Related Posts

Our Vision of Autoimmune Care

Autoimmune Patient Journey The convoluted journey of patients with autoimmune and inflammatory diseases (AIIDs) has many stages. Unlike cancer, diabetes, and heart disease, there are no population screening nor public health education programs for AIIDs.

Autoimmune Incidence & Prevalence

Data Issues in Autoimmune Data for autoimmune diseases are substantially lacking and inconsistent. The US gathers no statistics on autoimmune diseases as a group, nor even national data on marquee diseases. Therefore, total autoimmune incidence